This paper reports the MEPS-HPLC-DAD method for the simultaneous determination of twelve azole drugs (bifonazole, butoconazole, clotrimazole, econazole, itraconazole, ketoconazole, miconazole, posaconazole, ravuconazole, terconazole, tioconazole, voriconazole) administered to treat different systemic and topical fungal infections in biological samples. Azole drugs separation was performed in 36 minutes. The analytical method was validated in the ranges as follows: 0.02–5 µg mL-1 for ravuconazole; 0.2–5 µg mL-1 for terconazole; 0.05–5 µg mL-1 for the other compounds. Human plasma and urine were used as biological samples during the analysis; while benzyl-4-hydroxybenzoate was used as an internal standard. The precision (RSD%) and trueness (Bias%) values fulfill with International Guidelines requirements. To the best of our knowledge, this is the first HPLC-DAD procedure coupled to MEPS, which provides the simultaneous analysis of twelve azole drugs, available in the market, in human plasma and urine. Moreover, the method was succesfully applied for the quantitative determination of two model drugs (itraconazole and miconazole) after oral administration in real samples.

Analysis of imidazoles and triazoles in biological samples after MicroExtraction by Packed Sorbent

CAMPESTRE, Cristina;LOCATELLI, Marcello
;
CELIA, Christian;DI MARZIO, Luisa;CARRADORI, Simone
2017-01-01

Abstract

This paper reports the MEPS-HPLC-DAD method for the simultaneous determination of twelve azole drugs (bifonazole, butoconazole, clotrimazole, econazole, itraconazole, ketoconazole, miconazole, posaconazole, ravuconazole, terconazole, tioconazole, voriconazole) administered to treat different systemic and topical fungal infections in biological samples. Azole drugs separation was performed in 36 minutes. The analytical method was validated in the ranges as follows: 0.02–5 µg mL-1 for ravuconazole; 0.2–5 µg mL-1 for terconazole; 0.05–5 µg mL-1 for the other compounds. Human plasma and urine were used as biological samples during the analysis; while benzyl-4-hydroxybenzoate was used as an internal standard. The precision (RSD%) and trueness (Bias%) values fulfill with International Guidelines requirements. To the best of our knowledge, this is the first HPLC-DAD procedure coupled to MEPS, which provides the simultaneous analysis of twelve azole drugs, available in the market, in human plasma and urine. Moreover, the method was succesfully applied for the quantitative determination of two model drugs (itraconazole and miconazole) after oral administration in real samples.
File in questo prodotto:
File Dimensione Formato  
Journal of Enzyme Inhibition and Medicinal Chemistry (2017) 32(1) 1053-1063.pdf

accesso aperto

Tipologia: PDF editoriale
Dimensione 1.71 MB
Formato Adobe PDF
1.71 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11564/672148
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 32
social impact